SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028717
Filing Date
2016-11-09
Accepted
2016-11-09 17:20:13
Documents
71
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mack-10q_20160930.htm 10-Q 1881698
2 EX-31.1 mack-ex311_7.htm EX-31.1 9528
3 EX-31.2 mack-ex312_6.htm EX-31.2 9515
4 EX-32.1 mack-ex321_9.htm EX-32.1 5712
5 EX-32.2 mack-ex322_8.htm EX-32.2 5677
  Complete submission text file 0001564590-16-028717.txt   6820202

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20160930.xml EX-101.INS 1409462
7 XBRL TAXONOMY EXTENSION SCHEMA mack-20160930.xsd EX-101.SCH 55882
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20160930_cal.xml EX-101.CAL 54331
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20160930_def.xml EX-101.DEF 179382
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20160930_lab.xml EX-101.LAB 409893
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20160930_pre.xml EX-101.PRE 321822
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 161985204
SIC: 2834 Pharmaceutical Preparations